ReviewAnimals : an open access journal from MDPI2026
Fibropapillomatosis in Green Sea Turtles (
Review in Animals : an open access journal from MDPI, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fibropapillomatosis (FP) is a disease that threatens the health and safety of sea turtles globally, with green sea turtles having the highest FP prevalence. FP is associated with Chelonid alphaherpesvirus 5, but the primary etiological agent remains unknown as expression and severity of the virus are influenced by host susceptibility, immunological status, development of epithelial lesions, and environmental factors. This review explores current understanding of FP in green sea turtles, focusing on etiology, pathological features, diagnostic approaches, and rehabilitation strategies. Emphasis is placed on the compounded nature of the disease, integrating factors that influence disease expression. Screening challenges are examined through the limitations of clinical, histological, and molecular methods, particularly in distinguishing latent from active infection. Rehabilitation practices, including surgical intervention and long-term supportive care, are evaluated in the context of treatment outcomes and recurrence risk. Collectively, the evidence supports the interpretation of FP as a disease shaped by host-pathogen-ecology interactions. Improved integration of diagnostic tools and greater focus on natural drivers are essential for advancing understanding of the disease and informing conservation and management efforts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.